摘要
当今,靶向治疗成为肿瘤治疗模式里越来越重要的因子,而靶向治疗中研究最多的是关于表皮生长因子受体(epidermal growth factor receptor,EGFR)靶向治疗药物.随着临床的深入研究,EGFR分子靶向药物的临床应用利弊也成为关注的焦点.此文就EGFR在结直肠癌靶向治疗中的研究进展作一综述.
Targeted therapy has evolved recently as an important treatment modality for cancer,and the most extensively studied pathways for targeted therapy are those related to the drugs of epidermal growth factor receptor （EGFR）.Much attention has been paid to the advantages and disadvantages of these drugs in clinical application.This paper provides a literature review of the recent advances in EGFR-targeted therapy of colorectal cancer.
出处
《世界华人消化杂志》
CAS
北大核心
2010年第17期1804-1809,共6页
World Chinese Journal of Digestology
关键词
表皮生长因子受体
靶向治疗
结直肠癌
Epidermal growth factor receptor
Targeted therapy
Colorectal cancer
